Seamlessly expanding a randomized phase II trial to phase III.
about
Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological ReviewModeling the relationship between progression-free survival and overall survival: the phase II/III trial.Predictive power to assist phase 3 go/no go decision based on phase 2 data on a different endpoint.Randomized phase II trials: a long-term investment with promising returnsAdaptive clinical trial designs in oncology.Biomarker driven population enrichment for adaptive oncology trials with time to event endpoints.The use of Bayesian hierarchical models for adaptive randomization in biomarker-driven phase II studiesInnovative Clinical Trial Designs: Toward a 21st-Century Health Care SystemSequential design of phase II-III cancer trials.Bayesian clinical trials.Development of growth inhibitory agents in urological and other malignancies.Controlled multi-arm platform design using predictive probability.A comparison of phase II study strategies.Adaptive designs for randomized trials in public health.Phase II clinical trials in oncology: are we hitting the target?Discussion on "A Hybrid Selection and Testing Procedure with Curtailment for Comparative Clinical Trials" by Elena M. Buzaianu and Pinyuen Chen.Clinical trial end points for high-grade glioma: the evolving landscape.Role of randomized phase III trials in an era of effective targeted therapies.A novel evaluation of optimality for randomized controlled trials.Regulatory perspectives on multiplicity in adaptive design clinical trials throughout a drug development program.Adaptive methods: telling "the rest of the story".Dose selection in seamless phase II/III clinical trials based on efficacy and safety.Designing a seamless phase II/III clinical trial using early outcomes for treatment selection: an application in multiple sclerosis.Monitoring event times in early phase clinical trials: some practical issues.Methodology and Application of Adaptive and Sequential Approaches in Contemporary Clinical Trials
P2860
Q26766584-B3E34DBB-1BEA-4392-A3AE-BD1104A2877AQ34040130-43DC660C-C2F6-4343-9B26-8600048EFA96Q34149644-E1C0C61D-6FAD-4743-9684-0A6367CCE55FQ35115259-FDE2CDEA-02C2-48C0-A6A5-811B73FC4BC2Q35206844-0C4C5921-5670-4518-A2A1-A57B850256BAQ35226583-B672B442-213A-455B-89B9-7DDD456A467CQ35693300-BC042D6F-27C1-4695-9942-60A5DCDDCD07Q35797280-6EBB84F6-2CDC-4D61-A439-B19EF29ABEBCQ35940107-423461C5-14DD-4BCA-BF56-02B1C874678AQ36399554-7D2973C3-D97D-431F-BE1A-969FAC29DDA1Q36530430-47AF9A28-7D73-42CD-82D1-98D548D0E676Q37289826-93917804-BA0B-40EB-B2F4-DC6F17212ADEQ37375886-9115A726-22F6-440B-A4F9-331601386D74Q37417713-BA897BB7-6720-4C78-90D0-F035345CD21DQ37705422-3342FF3D-06CE-47EC-83DF-579252A7660BQ37771865-8B14B3CC-8D0A-4189-BF43-1BF55ADC05EBQ37839482-01AFD3B8-341A-4F65-A493-ED3216BD15CAQ37964935-A3F3DDF3-B6FE-44C3-9BED-B6AD78AB1E95Q39687668-147ACC08-6ADB-47AF-8586-86A5637169E7Q44490906-793A3D5A-7BE2-4A0B-9CD4-6FEF15286318Q44711945-EE53481E-F54D-4F41-A5B4-00C2F403AD03Q46029341-9F48665C-0AFF-4F76-A7BA-C8B2F899540BQ48152166-1DEF5541-BB39-41CA-9869-E7D2617E9466Q51955637-C5BC1F67-C737-46F7-8A0E-3BED7FB5E39CQ58910970-705C69FF-7842-48D9-9B4A-220ACFA19FA0
P2860
Seamlessly expanding a randomized phase II trial to phase III.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Seamlessly expanding a randomized phase II trial to phase III.
@en
Seamlessly expanding a randomized phase II trial to phase III.
@nl
type
label
Seamlessly expanding a randomized phase II trial to phase III.
@en
Seamlessly expanding a randomized phase II trial to phase III.
@nl
prefLabel
Seamlessly expanding a randomized phase II trial to phase III.
@en
Seamlessly expanding a randomized phase II trial to phase III.
@nl
P2093
P2860
P1433
P1476
Seamlessly expanding a randomized phase II trial to phase III.
@en
P2093
Donald A Berry
Lurdes Y T Inoue
Peter F Thall
P2860
P304
P356
10.1111/J.0006-341X.2002.00823.X
P407
P577
2002-12-01T00:00:00Z